Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes-Reference-Cited by-同舟云学术

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes

Published:2015-11-02 Issue:4 Volume:1 Page:440-446
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Weston Philip S.J.¹,Paterson Ross W.¹,Modat Marc¹²,Burgos Ninon²,Cardoso Manuel J.¹²,Magdalinou Nadia³,Lehmann Manja¹,Dickson John C.⁴,Barnes Anna⁴,Bomanji Jamshed B.⁴,Kayani Irfan⁴,Cash David M.¹,Ourselin Sebastien²,Toombs Jamie⁵,Lunn Michael P.⁵,Mummery Catherine J.¹,Warren Jason D.¹,Rossor Martin N.¹,Fox Nick C.¹,Zetterberg Henrik⁵⁶,Schott Jonathan M.¹

Affiliation:

1. Dementia Research CentreDepartment of Neurodegenerative DiseaseUCL Institute of NeurologyLondonUK

2. Transitional Imaging Group, Centre for Medical Image Computing, University College LondonLondonUK

3. Reta Lila Weston Institute of Neurological StudiesDepartment of Molecular NeuroscienceUCL Institute of NeurologyLondonUK

4. Institute of Nuclear Medicine, University College London HospitalsLondonUK

5. MRC Centre for Neuromuscular Disease, Department of Molecular NeuroscienceUCL Institute of Neurology, University College LondonLondonUK

6. Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of GothenburgMölndalSweden

Funder

Engineering and Physical Sciences Research Council

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.dadm.2015.10.001

Reference28 articles.

1. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2. CSF markers for incipient Alzheimer's disease

3. Use of Florbetapir-PET for Imaging β-Amyloid Pathology

4. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

5. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurogenetic motor disorders;Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders;2023

2. Retinal phenotyping of variants of Alzheimer's disease using ultra‐widefield retinal images;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2021-01

3. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy;Journal of Alzheimer's Disease;2020-04-21

4. A New Rat Model of Chronic Cerebral Hypoperfusion Resulting in Early-Stage Vascular Cognitive Impairment;Frontiers in Aging Neuroscience;2020-04-15

5. Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer’s disease;Alzheimer's Research & Therapy;2019-07-18